Loveland Business Briefs for Jan. 14: Olander honor, Oncology Patient Assistance fundraiser, patents

[ad_1] Todd Olander, farmer and founder of Olander Farms and Root Shoot Malting, ​has been named a member of the 2024 class of the Imbibe 75. (Root Shoot Malting/Courtesy Photo) In…

MaaT Pharma, Leader in Development of Microbiome-Based Therapies in Oncology, Awarded Government Funding for Clinical Development of MaaT033 as part of the France 2030 Plan

[ad_1] MaaT Pharma secures important funding in line with one of the goals under the Health Innovation 2030 Plan, the health component of ‘France 2030’, led by the Health Innovation…

Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.

[ad_1] AGOURA HILLS, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We” or “Our”), announced today its Chief Executive Officer (“CEO”), Dr. Vuong…

EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023 | BioSpace

[ad_1] ROCKLAND, Mass.–(BUSINESS WIRE)– EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that 28 abstracts featuring the latest research on the…

Oncology Territory Manager, Indianapolis, IN – Switzerland | Merck

[ad_1]   Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe…

Regional Value Demonstration Director – Oncology – Switzerland | Merck

[ad_1]   Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe…

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

[ad_1] Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® (adagrasib), a…

Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies

[ad_1] INDIANAPOLIS, Oct. 3, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today announced a definitive agreement for Lilly to acquire POINT, a radiopharmaceutical company with…

USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024

[ad_1] USMI to Debut the Canady Robotic AI Surgical System at the First …  WV News [ad_2] Source link

Singapore-based firm considers sale of Hong Kong oncology centres

[ad_1] TE Asia Healthcare Partners is considering selling its oncology centres in Hong Kong, according to people with knowledge of the matter. The Singapore-based company, backed by private equity firm…